{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpModified.=2021-03-02T14%3A55%3A25.339Z&min-date=2019-06-14&answer.answeringMemberConstituency=Stratford-on-Avon", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?max-ddpModified.=2021-03-02T14%3A55%3A25.339Z&min-date=2019-06-14&answer.answeringMemberConstituency=Stratford-on-Avon", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpModified.=2021-03-02T14%3A55%3A25.339Z&min-date=2019-06-14&answer.answeringMemberConstituency=Stratford-on-Avon&_metadata=all", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&max-ddpModified.=2021-03-02T14%3A55%3A25.339Z&min-date=2019-06-14&answer.answeringMemberConstituency=Stratford-on-Avon", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpModified.=2021-03-02T14%3A55%3A25.339Z&min-date=2019-06-14&answer.answeringMemberConstituency=Stratford-on-Avon", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpModified.=2021-03-02T14%3A55%3A25.339Z&min-date=2019-06-14&answer.answeringMemberConstituency=Stratford-on-Avon", "items" : [{"_about" : "http://data.parliament.uk/resources/1293264", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1293264/answer", "answerText" : {"_value" : "
Public Health England has published early estimates of vaccine effectiveness which includes the United Kingdom variant of concern VOC202012/01, which is available at the following link:<\/p>
<\/p>
https://www.medrxiv.org/content/10.1101/2021.03.01.21252652v1<\/a><\/p> <\/p> The 2021 Budget provided an extra £1.65 billion for the COVID-19 vaccination programme. This included £28 million to increase the UK\u2019s capacity for vaccine testing, support for clinical trials and improve the ability to rapidly acquire samples of new variants of COVID-19 and £22 million for a world-leading study to test the effectiveness of combinations of different vaccines. This will also fund the world\u2019s first study assessing the effectiveness of a third dose of vaccine to improve the response against current and future variants of COVID-19. A further £5 million investment in clinical-scale mRNA manufacturing has been allocated to create a \u2018library\u2019 of vaccines that will work against COVID-19 variants for possible rapid response deployment.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-03-23", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-03-23T10:58:08.767Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-03-01", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what plans his Department has to monitor the effectiveness of existing covid-19 vaccines against new variants of the SARS-CoV-2 virus.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
}
, "tablingMemberConstituency" : {"_value" : "Strangford"}
, "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
], "uin" : "160666"}
, {"_about" : "http://data.parliament.uk/resources/1293265", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1293265/answer", "answerText" : {"_value" : " Public Health England (PHE) is monitoring vaccine effectiveness in all eligible groups.<\/p> <\/p> PHE has published an assessment on vaccine effectiveness in adults aged 70 years and older and in healthcare workers, which is available at the following link:<\/p> <\/p> https://www.medrxiv.org/content/10.1101/2021.03.01.21252652v1<\/a><\/p> <\/p> As the COVID-19 vaccination programme continues in younger age groups, vaccine effectiveness estimates in these age groups will be published.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-03-23", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-03-23T10:54:15.443Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-03-01", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what plans his Department has to monitor the effectiveness of different covid-19 vaccines in different age groups.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
}
, "tablingMemberConstituency" : {"_value" : "Strangford"}
, "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
], "uin" : "160667"}
, {"_about" : "http://data.parliament.uk/resources/1293266", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1293266/answer", "answerText" : {"_value" : " The Government is currently reviewing whether COVID-19 status certification could play a role in reopening the economy, reducing restrictions on social contact and improving safety. This will include assessing to what extent certification would be effective in reducing risk and the potential uses to enable access to settings or a relaxation of COVID-19 secure mitigations. The Government will also consider the ethical, equalities, privacy, legal and operational aspects of this approach and what limits, if any, should be placed on organisations using certification. It will draw on external advice to develop recommendations that take into account any social and economic impacts and implications for disproportionately impacted groups and individuals\u2019 privacy and security.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-03-25", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-03-25T10:11:37.047Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-03-01", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "NHS Covid Pass"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential effectiveness of vaccine passports.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
}
, "tablingMemberConstituency" : {"_value" : "Strangford"}
, "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
], "uin" : "160668"}
, {"_about" : "http://data.parliament.uk/resources/1293285", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1293285/answer", "answerText" : {"_value" : " There should be no case where a patient would only be offered an invitation via digital means, or where the only way to book would be online. Invitations for the vaccines are currently being issued in a number of ways. The National Booking Service is primarily sending invitation letters to people\u2019s registered addresses. These letters, sent in size 16 font as standard as defined by RNIB as large print, give the option of booking online, or by the free 119 phone line. This phone line includes BSL and text relay services. Others can make an appointment on behalf of individuals who are not able to make it themselves. Follow up phone calls and letters are made to those who have been sent an initial letter but not responded.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-03-22", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-03-22T12:04:53.043Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-03-01", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he has taken to ensure that people who are digitally excluded are included in the covid-19 vaccination programme.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1491", "label" : {"_value" : "Biography information for Kerry McCarthy"}
}
, "tablingMemberConstituency" : {"_value" : "Bristol East"}
, "tablingMemberPrinted" : [{"_value" : "Kerry McCarthy"}
], "uin" : "160558"}
, {"_about" : "http://data.parliament.uk/resources/1293288", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1293288/answer", "answerText" : {"_value" : " The Department has built a library of material to support trusted conversations and provide information to employers that is accessible and relevant to social care workers, including those who work in care homes. These resources focus on tackling hesitancy, misinformation, and include content relevant to black, Asian and minority ethnic groups and cover specific topics such as fertility and vaccine ingredients.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-03-22", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-03-22T12:03:03.45Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-03-01", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Care Homes: Coronavirus"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he will take to tackle covid-19 vaccine hesitancy amongst care home staff in England.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1491", "label" : {"_value" : "Biography information for Kerry McCarthy"}
}
, "tablingMemberConstituency" : {"_value" : "Bristol East"}
, "tablingMemberPrinted" : [{"_value" : "Kerry McCarthy"}
], "uin" : "160560"}
, {"_about" : "http://data.parliament.uk/resources/1293320", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1293320/answer", "answerText" : {"_value" : " We have opened the National Booking Service to eligible frontline health or social care workers which provides an additional option for them to access a vaccination appointment at a time and place that is convenient for them. Furthermore, a programme of work is underway at the national and local level to support and encourage vaccine uptake among staff in health and social care working in all settings. The National Health Service has produced guidance to support NHS organisations in vaccinating their workforce including engagement guides, checklists, and frequently asked questions documents.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-03-22", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-03-22T11:59:20.767Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-03-01", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to encourage vaccine take up among health and social care staff working in all settings.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4676", "label" : {"_value" : "Biography information for Marsha De Cordova"}
}
, "tablingMemberConstituency" : {"_value" : "Battersea"}
, "tablingMemberPrinted" : [{"_value" : "Marsha De Cordova"}
], "uin" : "160792"}
, {"_about" : "http://data.parliament.uk/resources/1293339", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1293339/answer", "answerText" : {"_value" : " Our investment in the Coalition for Epidemic Preparedness Innovations (CEPI) supports ongoing vaccine research and development to respond to an evolving virus. Whilst there are no current plans for United Kingdom Government-initiated international research into the COVID-19 vaccine response on immunocompromised groups, it is important to emphasise that the research community is truly global in its collaboration and studies, those planned or published, will be shared, discussed and closely scrutinised by international researchers in this field and vice versa.<\/p> UK Research and Innovation is funding research on vaccine responses in groups of immune-suppressed individuals specifically, as part of its support for the OCTAVE study. This study includes those with inflammatory disorders, high risk cancer patient groups, and patients with severe kidney and liver disease.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-04-13", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-04-13T15:29:09.263Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-03-01", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what plans he has for international collaboration on research into the covid-19 vaccine response in immunocompromised groups.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/3960", "label" : {"_value" : "Biography information for Henry Smith"}
}
, "tablingMemberConstituency" : {"_value" : "Crawley"}
, "tablingMemberPrinted" : [{"_value" : "Henry Smith"}
], "uin" : "160620"}
, {"_about" : "http://data.parliament.uk/resources/1293340", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1293340/answer", "answerText" : {"_value" : " By mid-February we successfully offered a first vaccine dose to everyone in the top four priority groups identified by the Joint Committee on Vaccination and Immunisation (JCVI), including clinically extremely vulnerable (CEV) individuals. The National Health Service across the United Kingdom will continue prioritising the first dose of the vaccine to those in the most high-risk groups; however, this will not interfere with everyone receiving their second dose within 12 weeks of their first. The second dose completes the course and is important for longer term protection.<\/p> As virus infection rates continue to fall, advice to CEV individuals to shield will cease from 1 April, but they must continue to follow the rules in place for everyone under the current national restrictions. Those on the shielded patient list will receive letters with updated guidance on steps people can take to reduce their risk.<\/p> Regarding longer term support for CEV individuals, local councils will continue to provide support to those in their communities in need and have systems and relationships in place with other organisations to provide that. The NHS Volunteer Responders Programme will also continue providing support with food, prescriptions and essential items to those who are self-isolating for any reason. This also includes anyone that is clinically extremely vulnerable, or anyone that is vulnerable for another reason.<\/p>